Leerink Partners analyst Danielle Antalffy maintained a Hold rating on Inogen (INGN – Research Report) yesterday. The company's shares closed last Tuesday at $30.73, close to its 52-week low of $29.28. According to TipRanks.com, Antalffy is a 4-star analyst with an average return of 10.3% and a 54.2% success rate. Antalffy covers the Healthcare sector, focusing on stocks such as Axonics Modulation Technologies, Inspire Medical Systems, and Treace Medical Concepts. Inogen has an analyst consensus of Hold, with a price target consensus of $44.00. See Insiders’ Hot Stocks on TipRanks >> The company has a one-year high of $82.35 and a one-year low of $29.28.
https://www.tipranks.com/news/blurbs/inogen-ingn-receives-a-hold-from-leerink-partners?utm_source=advfn.com&utm_medium=referral
Inogen (NASDAQ:INGN)
Historical Stock Chart
From Apr 2022 to May 2022 Click Here for more Inogen Charts.
Inogen (NASDAQ:INGN)
Historical Stock Chart
From May 2021 to May 2022 Click Here for more Inogen Charts.